Nav: Home

Nipping flu pandemics in the bud

May 10, 2017

The threat of a major flu pandemic is a perennial concern. Now scientists have developed a fast and easy-to-use point-of-care diagnostic test that could one day help doctors and hospitals head off the rapid spread of the flu. They report their new device in ACS' journal Analytical Chemistry.

The gold standard of flu diagnostics involves expensive techniques, laboratory facilities, trained personnel and, most importantly, time. However, patients and doctors often don't have time on their side because some strains, such as H5N1, can cause severe illness and even death. And even common strains can be deadly in the elderly and small children. Existing rapid diagnostic tests can help with diagnoses, but these tests require multiple processing steps that still need to be performed with lab equipment in specialized facilities. So Paul Yager and colleagues set out to create a simpler, low-cost device that can be used during an office or hospital visit without expensive instruments.

The researchers incorporated multiple steps of influenza detection -- viral lysis, target protein capture, labeling, rinsing and an enzyme-driven color change -- into one device. A user has to swab the inside of a patient's nose, then insert the swab into the device and twirl it for 10 seconds to release the virus. The device takes care of the rest. After about 35 minutes, it produces a visual readout that can be seen with the naked eye or captured with a smartphone camera. The researchers trained staff at a children's hospital to use the device, and they tested it on 25 patients during a flu outbreak. The device detected influenza A, one of the primary causes of moderate to severe flu epidemics, with 70 percent accuracy. The materials and reagents for one of these single-use devices cost less than $6.
-end-
The authors acknowledge funding from the National Institutes of Health.

The abstract that accompanies this study is available here.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Follow us on Twitter | Facebook

American Chemical Society

Related Flu Articles:

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.
These less common proteins may help fend off the flu
Influenza type B, though generally less widespread than type A, poses a formidable threat for vulnerable populations like the elderly and the young.
Flu, flu-like illnesses linked to increased risk of stroke, neck artery tears
Flu-like illnesses are associated with an increased risk of stroke and neck artery dissection.
Close flu vaccine supply gaps to ease flu seasons, make pandemics less deadly
Gaps in the logic of how we restock flu vaccines may be costing hundreds of lives, or more.
A new approach to studying the flu
A clever repurposing of a biological tool gives researchers new clues as to how the flu remains so successful.
More Flu News and Flu Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...